MeSH D012640 - seizures
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009461:Neurologic manifestations
D012640:Â
Seizures
D000091323:Psychogenic nonepileptic seizures
0 Companies
0 Drugs
Success rate
D013226:Status epilepticus
D020270:Alcohol withdrawal seizures
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Clobazam | Clobazam |  | 2020-01-31 |  |  |
| Clonazepam | Clonazepam |  | 1996-09-10 |  |  | |
| Lamotrigine | Lamotrigine |  | 2006-08-30 |  |  | |
| Pregabalin | Pregabalin |  | 2019-07-19 |  |  | |
| Taro Pharmaceutical | Clobazam | Clobazam |  | 2018-10-22 |  |  |
| Lamotrigine | Lamotrigine |  | 2009-01-27 |  |  | |
| Glenmark Pharmaceuticals | Lamotrigine | Lamotrigine |  | 2009-02-19 |  |  |
| Rufinamide | Rufinamide |  | 2016-05-16 |  |  | |
| Mylan | Clobazam | Clobazam |  | 2018-10-22 |  |  |
| Clonazepam | Clonazepam |  | 1997-10-30 |  |  | |
| Fosphenytoin | Fosphenytoin |  | 2010-06-08 |  |  | |
| Lamotrigine | Lamotrigine |  | 2009-01-22 |  |  | |
| Pregabalin | Pregabalin |  | 2019-09-20 |  |  | |
| Pregabalin | Pregabalin Mylan |  | 2015-06-24 |  |  | |
| Pregabalin | Pregabalin Mylan Pharma |  | 2015-06-25 |  |  | |
| Rufinamide | Rufinamide |  | 2016-05-16 |  |  | |
| NATCO Pharma | Lamotrigine | Lamotrigine |  | 2009-01-27 |  |  |
| GSK | Lamotrigine | Lamictal |  | 1994-12-27 |  |  |
| Roche | Folic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Vitamin a, Biotin, Niacinamide, Pyridoxine, Riboflavin, Thiamine | Berocca Pn |  | 1985-10-10 |  |  |
| Clonazepam | Klonopin Rapidly Disintegrating |  | 1997-12-23 |  |  | |
| Cipla | Pregabalin | Pregabalin |  | 2019-07-19 |  |  |
| Lupin Research | Clobazam | Clobazam |  | 2018-12-14 |  |  |
| Lamotrigine | Lamotrigine |  | 2010-06-01 |  |  | |
| Pregabalin | Pregabalin |  | 2022-05-03 |  |  | |
| Rufinamide | Rufinamide |  | 2022-08-17 |  |  | |
| Fosphenytoin | Sesquient | 2029-03-13 | 2020-11-05 |  |  | |
| Brivaracetam | Brivaracetam |  | 2022-12-20 |  |  |
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
100%17/17
Phase 2
50%17/34
Phase 3
69%29/42
Approved: 14Overall Success rate: 35%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
7
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use